My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 317

    1.

    Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

    Quattrin T, Bélanger A, Bohannon NJ, Schwartz SL; Exubera Phase III Study Group.

    Diabetes Care. 2004 Nov;27(11):2622-7.PMID: 15504996 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

    Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson JL, Levin SR.

    Diabetes Care. 2004 Oct;27(10):2356-62.PMID: 15451900 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.

    Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC; Inhaled Insulin Phase III Type 1 Diabetes Study Group.

    Diabetes Care. 2005 Jul;28(7):1630-5.PMID: 15983312 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

    Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

    Ann Intern Med. 2005 Oct 18;143(8):549-58.PMID: 16230721 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.

    Rosenstock J, Cefalu WT, Hollander PA, Belanger A, Eliaschewitz FG, Gross JL, Klioze SS, St Aubin LB, Foyt H, Ogawa M, Duggan WT.

    Diabetes Care. 2008 Sep;31(9):1723-8. Epub 2008 Jun 5.PMID: 18535196 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.

    Skyler JS, Jovanovic L, Klioze S, Reis J, Duggan W; Inhaled Human Insulin Type 1 Diabetes Study Group.

    Diabetes Care. 2007 Mar;30(3):579-85.PMID: 17327324 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Inhaled dry powder insulin for the treatment of diabetes mellitus.

    Setter SM, Levien TL, Iltz JL, Odegard PS, Neumiller JJ, Baker DE, Campbell RK.

    Clin Ther. 2007 May;29(5):795-813. Review.PMID: 17697900 [PubMed - indexed for MEDLINE]Related articles

    8.

    Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.

    Ceglia L, Lau J, Pittas AG.

    Ann Intern Med. 2006 Nov 7;145(9):665-75.PMID: 17088580 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    10.

    An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with metformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea.

    Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M.

    Diabetes Care. 2006 Jun;29(6):1282-7.PMID: 16732009 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (exubera).

    Norwood P, Dumas R, Cefalu W, Yale JF, England R, Riese R, Teeter J.

    J Clin Endocrinol Metab. 2007 Jun;92(6):2211-4. Epub 2006 Sep 26.PMID: 17003088 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

    Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

    Clin Ther. 2004 Apr;26(4):502-10.PMID: 15189747 [PubMed - indexed for MEDLINE]Related articles

    13.

    Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.

    Cappelleri JC, Cefalu WT, Rosenstock J, Kourides IA, Gerber RA.

    Clin Ther. 2002 Apr;24(4):552-64.PMID: 12017400 [PubMed - indexed for MEDLINE]Related articles

    14.

    Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.

    Moses RG, Bartley P, Lunt H, O'Brien RC, Donnelly T, Gall MA, Vesterager A, Wollmer P, Roberts A.

    Diabet Med. 2009 Mar;26(3):260-7.PMID: 19317821 [PubMed - indexed for MEDLINE]Related articles

    15.

    Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

    Rosenstock J, Cappelleri JC, Bolinder B, Gerber RA.

    Diabetes Care. 2004 Jun;27(6):1318-23.PMID: 15161782 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    17.

    The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study.

    Heise T, Bott S, Tusek C, Stephan JA, Kawabata T, Finco-Kent D, Liu C, Krasner A.

    Diabetes Care. 2005 Sep;28(9):2161-9.PMID: 16123484 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial.

    Gerber RA, Cappelleri JC, Kourides IA, Gelfand RA.

    Diabetes Care. 2001 Sep;24(9):1556-9.PMID: 11522698 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity